Released on: July 17, 2008, 8:48 am

Press Release Author: Exco InTouch

Industry:

Press Release Summary: Exco InTouch, the leading mobile messaging provider for the
pharmaceutical industry, announces that the DIA 44th Annual Meeting 2008 represented
a growing shift away from traditional patient communication techniques within
clinical trials. Direct-to-patient communication using cell phones is now emerging
as a viable alternative and can offer significant advantages in the areas of patient
recruitment, improving adherence and maximising patient retention. Exco InTouch
profited from the opportunity to meet with colleagues in the drug development
industry and discuss the evolution of technology in the pharmaceutical sector when
exhibiting at the DIA Annual Meeting in June 2008.

Press Release Body: (17 July, 2008) Exco InTouch, the leading mobile messaging
provider for the pharmaceutical industry, announces that the DIA 44th Annual Meeting
2008 represented a growing shift away from traditional patient communication
techniques within clinical trials. Direct-to-patient communication using cell phones
is now emerging as a viable alternative and can offer significant advantages in the
areas of patient recruitment, improving adherence and maximising patient retention.
Exco InTouch profited from the opportunity to meet with colleagues in the drug
development industry and discuss the evolution of technology in the pharmaceutical
sector when exhibiting at the DIA Annual Meeting in June 2008.

Tim Davis, Co-Founder of Exco InTouch, comments: "The methods we use to communicate
within the clinical trial framework are changing in line with facilitating
participation for the patient. The use of cell phone technology is now ubiquitous
across the globe, and SMS text message communication enables sponsors to fully
interact with patients and investigators while maintaining compliance with the
strict regulations covering communication within clinical trials. The spectrum of
attendees at DIA, from pharmaceutical sponsors through clinical trials
investigators, provides a cross-section of trends in the industry, with a focus on
utilising new technology to improve communication during clinical trials."

Exco InTouch provides cost-effective, simple technology to communicate with and
elicit a response from patients. By utilising simple SMS technology, alerts are
delivered promptly to the patient participating in a clinical study via their own
mobile phone. These SMS methods are non-intrusive, offering healthcare providers
with a simple cost-effective, personal, direct-to-patient system of communication.

The Exco InTouch portfolio of solutions is designed to improve subject recruitment,
retention and compliance during clinical trials and pharmaceutical marketing
studies, from delivering reminder services to patients to non-intrusive methods of
promoting investigator relationships. This technology has revolutionised clinical
trial communication, using Short Message Service (SMS) to send scheduled,
action-driven text messages directly to the mobile phone user, enhancing patient
relationship management.

Exco InTouch is the premier provider of global, secure and regulatory compliant
mobile solutions to the biopharmaceutical and healthcare industries. The Exco
InTouch technology is currently used by a number of large pharmaceutical companies
in support of their clinical trials and marketing programs.

For further information on the Exco InTouch portfolio of solutions, please call +44
1279 408 210 or +1 949 725 2946 or visit www.excointouch.com

-ENDS-

For further press information please contact: Eleanor CallanMonk, The Scott
Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA Tel: +44
1477 539539 Fax: +44 1477 539540 e-mail: exco@scottpr.com


Web Site: http://www.excointouch.com

Contact Details: THE SCOTT PARTNERSHIP
1 WHITESIDE
STATION ROAD
HOLMES CHAPEL
CHESHIRE
CW4 8AA
01477 539539
exco@scottpr.com